Current concepts of fetal growth restriction: Part I. Causes, classification, and pathophysiology

Obstetrics and Gynecology

Volumn 92, Issue 6, 1998, Pages 1044-1055

  Lin, Chin Chu ^a   Santolaya Forgas, Joaquin ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH WEIGHT; DATA ANALYSIS; DISEASE CLASSIFICATION; FETUS GROWTH; HUMAN; INTRAUTERINE GROWTH RETARDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; FETAL GROWTH RETARDATION; GLUCOSE; HUMANS; RESEARCH; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0032403596     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00328-7     Document Type: Review

References (126)

1. Lubchenco L.O., Hansman C., Dressler M., Boyd E. Intrauterine growth as estimated from live birth weight data at 24 to 42 weeks of gestation. Pediatrics. 32:1963;793-800.
2. Battaglia F.C., Lubchenco L.O. A practical classification of newborn infants by weight and gestational age. J Pediatr. 71:1967;159-163.
3. Lin C.C., Evans M.I. Intrauterine growth retardation Pathophysiology and clinical management . 1984;McGraw-Hill, New York.
4. Lin C.C. Intrauterine growth retardation. Wynn R.M. Obstetrics and gynecology annual. 1985;127-221 Appleton-Century-Crofts, Norwalk, Connecticut.
5. Lin C.C. Pathophysiology of perinatal hypoxia in fetuses with intrauterine growth retardation. Maeda K., Okuyama K., Takeda Y. Recent advances in perinatology. 1986;55-62 Excerpta Medica, Amsterdam.
6. Lin C.C. Perinatal hypoxia in the growth retarded fetus basic pathophysiology and clinical management . Rathi M.L. Current perinatology. 1989;1-24 Springer-Verlag, New York.
7. Kurjak A., Beazley J.M. Fetal growth retardation diagnosis and treatment . 1989;CRC Press, Boca Raton, Florida.
8. Pollack R.N., Divon M.Y. Intrauterine growth retardation definition, classification, and etiology . Clin Obstet Gynecol. 35:1992;99-107.
9. Lin C.C. Fetal growth retardation. Lin C.C., Verp M.S., Sabbagha R.E. The high-risk fetus. 1993;360-394 Springer-Verlag, New York.
10. Cunningham F.G., MacDonald P.C., Gant N.F., Leveno K.J., Gilstrap L.C. III, Hankins G.D.V., et al. Williams obstetrics. 20th ed. 1997;839-854 Appleton & Lange, Norwalk, CT.
11. Gabbe S.G. Intrauterine growth retardation. Gabbe S.G., Niebyl J.R., Simpson J.L. Obstetrics normal and problem pregnancies . 3rd ed. 1996;863-886 Churchill Livingstone, New York.
12. Manning F.A. Intrauterine growth retardation. Manning F.A. Fetal medicine Principle and practice . 1995;307-393 Appleton & Lange, Norwalk, Connecticut.
13. Neerhof M.G. Causes of intrauterine growth retardation. Clin Perinatol. 22:1995;375-385.
14. Seeds J.W. Impaired fetal growth definition and clinical diagnosis . Obstet Gynecol. 64:1984;303-310.
15. Araki T. The time and the method of delivery in IUGR pregnancy. Maeda K., Okuyama K., Takeda Y. Recent advances in perinatology. 1986;299-306 Excerpta Medica, Amsterdam.
16. Patterson R.M., Pouliot M.R. Neonatal morphometrics and perinatal outcome who is growth retarded? Am J Obstet Gynecol. 157:1987;691-693.
17. Scott K.E., Usher R. Fetal malnutrition its incidence, causes and effect . Am J Obstet Gynecol. 94:1966;951-963.
18. Winick M. Cellular changes during placental and fetal growth. Am J Obstet Gynecol. 109:1971;166-176.
19. Rosso P., Winick M. Intrauterine growth retardation a new systemic approach based on the clinical and biochemical characteristics of this condition . J Perinat Med. 2:1974;147-160.
20. Williams R.L., Creasy R.K., Cunningham G.C., Hawes W.E., Norris F.D., Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol. 59:1982;624-632.
21. Lin C.C., Su S.J., River L.P. Comparison of associated high-risk factors and perinatal outcome between symmetric and asymmetric fetal intrauterine growth retardation. Am J Obstet Gynecol. 164:1991;1535-1542.
22. Bauld R., Sutherland C.R., Bain A.D. Chromosome studies in investigation of stillbirths and neonatal deaths. Arch Dis Child. 49:1974;782-788.
23. Nicolaides K.H., Snizders R.J.M., Noble P. Cordocentesis in the study of growth retarded fetuses. Divon M.Y. Abnormal fetal growth. 1991;163-177 Elsevier, New York.
24. Varner M.W., Galask R.P. Infectious causes. Lin C.C., Evans M.I. Intrauterine growth retardation. 1984;998-1116 McGraw-Hill, New York.
25. Moore G.E., Ali Z., Khan R.U., Blunt S., Bennen P.R., Vaughan J.I. The incidence of uniparenteral disomy associated with intrauterine growth retardation in a cohort of thirty-five severely affected babies. Am J Obstet Gynecol. 176:1997;294-299.
26. Kalvosek D.K., Barrett I. Genomic imprinting related to prenatal diagnosis. Prenat Diagn. 14:1994;1191-1201.
27. Robinson W.P., Barrett I.J., Telenius A. Meiotic origin of trisomy in confimed placental mosaicism is correlated with presence of uniparental disomy, high level of trisomy in trophoblast, and increased risk of fetal intrauterine growth restriction. Am J Hum Genet. 60:1997;917-927.
28. Guenwald P. Growth of the human fetus II. Abnormal growth in twins and infants of mothers with diabetes, hypertension, or isoimmunization . Am J Obstet Gynecol. 94:1966;1120-1132.
29. Houlton M.C., Marivate M., Philpott R.H. The prediction of fetal growth retardation in twin pregnancy. Br J Obstet Gynaecol. 88:1981;264-273.
30. Divon M.Y., Weiner Z. Ultrasound in twin pregnancy. Semin Perinatol. 19:1995;404-412.
31. D'Alton M.E., Simpson L.L. Syndromes in twins. Semin Perinatol. 19:1995;375-386.
32. Weissman A., Ackiron R., Lipitz S., Blickstein I., Mashiach S. The first trimester growth-discordant twin an omnious prenatal finding . Obstet Gynecol. 84:1994;110-114.
33. Malone F.D., Craigo S.D., Chelmow D., D'Alton M.E. Outcome of twin gestations complicated by a single anomalous fetus. Obstet Gynecol. 88:1996;1-5.
34. Brown D.L., Benson C.B., Driscoll S.G., Doubilet P.M. Twin-twin transfusion syndrome sonographic findings . Radiology. 170:1989;61-63.
35. Loke Y.W., King A. Human implantation cell biology and immunology . 1995;University Press, Cambridge.
36. Wallenburg H.C.S., Visser W. Pregnancy induced hypertensive disorders. Curr Opin Obstet Gynecol. 6:1994;19-29.
37. Pasto M.E., Kurtz A.B., Ritkin M.D., Cole-Benglet C., Wagner R., Goldberg G.G. Ultrasonographic findings in placenta increta. J Ultrasound Med. 2:1983;155-159.
38. Ling P.A., Abell D.A., Beischer N.A. Fetal growth retardation and preeclampsia. Br J Obstet Gynaecol. 87:1980;13-18.
39. Cunningham F.G., Cox S.M., Harstad T.W., Mason R.A., Pritchard J.A. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol. 163:1990;453-459.
40. Zulman J.I., Talal N., Hoffman G.S., Epstein W.V. Problems associated with the management of pregnancies in patients with systemic lupus erythematosus. J Rheumatol. 7:1980;327-349.
41. Lin C.C., Lindheimer M.D., River P., Moawad A.H. Fetal outcome in hypertensive disorders of pregnancy. Am J Obstet Gynecol. 142:1982;255-260.
42. Redman C.W.G. Chronic hypertension. Quilligan E.J., Zuspan F.P. Current therapy in obstetrics and gynecology. 1990;207-210 WB Saunders, Philadelphia.
43. Davidson J.M. Pregnancy in renal allograft recipients prognosis and management . Clin Obstet Gynecol. 1:1987;1027-1045.
44. Haworth J.C., Ellestad-Sayed J.J., King J., Dilling L.A. Fetal growth retardation in cigarette-smoking mothers is not due to decreased maternal food intake. Am J Obstet Gynecol. 137:1980;719-723.
45. Meyer M.B. How does maternal smoking affect birth weight and maternal weight gain? Evidence from the Ontario Perinatal Mortality Study . Am J Obstet Gynecol. 131:1978;888-893.
46. Jones K.L., Smith D.W., Ulleland C.N., Streissguth A.P. Pattern of malformation in offspring of chronic alcohol mothers. Lancet. 1:1973;1267-1271.
47. Hanson J.W., Myrianthopoulos N.C., Harvey M.A., Smith D.W. Risks to offspring of women treated with hydantoin anticonvulsants with emphasis on the fetal hydantoin syndrome. J Pediatr. 89:1976;662-668.
48. Hall J.G., Pauli R.M., Wilson K.M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 68:1980;122-140.
49. Little B.B., Snell L.M., Klein V.R., Gilstrap L.C. III. Cocaine abuse during pregnancy Maternal and fetal implications . Obstet Gynecol. 74:1989;157-160.
50. Koops B.L., Morgan L.J., Battaglia F.C. Neonatal mortality risk in relation to birth weight and gestational age Update . J Pediatr. 101:1982;969-977.
51. Goldenberg R.L., Nelson K.G., Koski J.F., Cutter G.R. Low birth weight intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol. 152:1985;980-984.
52. Ott W.J. Intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol. 168:1993;1710-1715.
53. Greiss F.C. Jr, Anderson S.G. Uterine blood flow during early ovine pregnancy. Am J Obstet Gynecol. 106:1970;30-38.
54. Makowski E.L., Meschia G., Droegemueller W., Battaglia F.C. Distribution of uterine blood flow in pregnant sheep. Am J Obstet Gynecol. 101:1968;409-412.
55. Rosenfield C.R., Morriss F.H. Jr, Makowski E.L., Meschia G., Battaglia F.C. Circulatory changes in the reproductive tissue of ewes during pregnancy. Gynecol Invest. 5:1974;252-268.
56. Greiss F.C. Jr. Uterine blood flow in pregnancy An overview . Moawad A.H., Lindheimer M.D. Uterine and placental blood flow. 1982;19-26 Masson, New York.
57. Schulman H. Doppler velocimetry of fetal and placental blood flow. Lin C.C., Verp M.S., Sabbagha R.E. The high-risk fetus. 1993;336-351 Springer-Verlag, New York.
58. Schulman H., Fleischer A., Farmakides G., Bracero L., Rochelson B., Grunfeld L. Development of uterine artery compliance in pregnancy as detected by Doppler ultrasound. Am J Obstet Gynecol. 155:1986;1031-1036.
59. Campbell S., Diaz-Recasens J., Griffin D.R., Choen-Overbek T.E., Pearce J.M. New Doppler technique for assessing uteroplacental blood flow. Lancet. 1:1983;675-677.
60. Schulman H., Ducey J., Farmakides G., Guzman E., Winder D., Penny B., et al. Uterine artery Doppler velocimetry The significance of divergent systolic/diastolic ratios . Am J Obstet Gynecol. 159:1989;1072-1076.
61. Akalin-Sel T., Campbell S. Understanding the pathophysiology of intrauterine growth retardation The role of the "lower limb reflex" in redistribution of blood flow . Eur J Obstet Gynecol Reprod Biol. 46:1992;79-86.
62. Arduini D., Rizzo G. Doppler studies of deteriorating growth retarded fetuses. Curr Opin Obstet Gynecol. 5:1993;195-203.
63. Fleischer A., Schulman H., Farmakides G., Bracero L., Blattner P., Randolph G. Umbilical artery velocity waveforms and intrauterine growth retardation. Am J Obstet Gynecol. 151:1985;502-505.
64. Giles W.B., Trudinger B.J., Baird P. Fetal umbilical artery flow velocity waveforms and placental resistance Pathologic correlation . Br J Obstet Gynaecol. 92:1985;31-38.
65. Gaziane E.P., Kno H., Ferrera B., Brandt D.G., Calvin S.E., Knox G.E. Is it time to reassess the risk for the growth retarded fetus with normal Doppler velocimetry of the umbilical artery? Am J Obstet Gynecol. 170:1994;1734-1741.
66. Wladimiroff J.W., Wijngaard J.A., Degani S., Noordan M.J., van Eyck J., Tonge H.M. Cerebral and umbilical arterial blood flow velocity waveforms in normal and growth retarded pregnancies. Obstet Gynecol. 69:1987;7705-7709.
67. Wladimiroff J.W. A review of the etiology, diagnostic techniques and management of IUGR, and the clinical application of Doppler in the assessment of placental blood flow. J Perinat Med. 19:1991;11-13.
68. Loy G.L., Lin C.C., Chien E.K.S., Kim J.H., Chiang L.M. Cerebral and umbilical resistance response to vibroacoustic stimulation in growth restricted fetuses. Obstet Gynecol. 90:1997;947-952.
69. Arduini D., Rizzo G., Romanini C. Changes of pulsatility index from fetal vessels preceding the onset of late decelerations in growth retarded fetuses. Obstet Gynecol. 79:1992;605-610.
70. Takagi K. Limit of antenatal management of intrauterine growth retarded fetus. Acta Obstet Gynaecol Jap. 45:1993;808-814.
71. Rochelson B. The clinical significance of absent end-diastolic velocity in the umbilical artery waveforms. Clin Obstet Gynecol. 32:1989;696-702.
72. Krebs C., Macaral M., Leiser R., Bowman A.W., Greer I.A., Kingdom J.C.P. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol. 175:1996;1534-1542.
73. Meschia G. Placenta respiratory gas exchange and fetal oxygenation. Creasy R.K., Resnik R. Maternal fetal medicine Principles and practice . 1st ed. 1987;274-285 WB Saunders, Philadelphia.
74. Meschia G., Battaglia F.C., Hay W.W., Sparks J.W. Utilization of substrates by the ovine placenta in vivo. Fed Proc. 39:1980;245-249.
75. Nitzan M., Groffman H. Hepatic gluconeogenesis and lipogenesis in experimental intrauterine growth retardation in the rat. Am J Obstet Gynecol. 109:1971;623-627.
76. Block B.S., Llanos A.J., Creasy R.K. Responses of the growth-retarded fetus to acute hypoxemia. Am J Obstet Gynecol. 148:1984;879-885.
77. Humbert J.R., Abelson H., Hathaway W.E., Battaglia F.C. Polycythemia in small for gestational age infants. J Pediatr. 75:1969;812-819.
78. Soothill P.W., Nicolaides K.H., Campbell S. Prenatalasphyxia, hyperlacticaemia, hypoglucosaemia, and erythroblastosis in growth retarded fetuses. BMJ. 294:1987;1051-1053.
79. 2, pH, lactate and erythroblast count in growth-retarded fetuses. Fetal Ther. 1:1985;176-179.
80. Lin C.C., Moawad A.H., Rosenow P.J., River L.P. Acid-base characteristics of fetuses with intrauterine growth retardation during labor and delivery. Am J Obstet Gynecol. 137:1980;553-559.
81. Nicolini U., Hubinont C., Santolaya J., Risk N.M., Coe A.M., Rodech C.H. Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated by alloimmunization and fetal growth retardation. Am J Obstet Gynecol. 161:1989;924-927.
82. Economides D.L., Nicolaides K.H. Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am J Obstet Gynecol. 160:1989;385-389.
83. Economides D.L., Nicolaides K.H., Gahl W.A., Bernardini I., Evans M.I. Plasma amino acids in appropriate and small-for-gestational-age fetuses. Am J Obstet Gynecol. 161:1989;1219-1227.
84. Owens J.A., Falconer J., Robinsin J.S. Effect of restriction of placental growth on fetal uteroplacental metabolism. J Dev Physiol. 9:1987;225-238.
85. Nicolini U., Hubinont C., Santolaya J., Fisk N.M., Rodeck C.H. Effects of fetal intravenous glucose challenge in normal and growth retarded fetuses. Horm Metab Res. 22:1990;426-430.
86. Hubinont C., Nicolini U., Fisk N.M., Tannirandorn Y., Rodeck C.H. Endocrine pancreatic function in growth-retarded fetuses. Obstet Gynecol. 77:1991;541-544.
87. Van Assche F.A., Aerts L., DePrins F.A. The fetal endocrine pancreas. Eur J Obstet Gynecol Reprod Biol. 18:1984;267-272.
88. Jones C.T., Ritchie J.W., Walker D. The effects of hypoxia on glucose turnover in the fetal sheep. J Dev Physiol. 5:1983;223-235.
89. Rebolledo O.R., Hernandez R.E., Zanetta A.C., Gagliardino J.J. Insulin secretion during acid-base alterations. Am J Physiol. 234:1978;E426-E439.
90. Khouzami V.A., Ginsburg D.S., Daikoku N.H., Johnson J.W. The glucose tolerance test as a means of identifying intrauterine growth retardation. Am J Obstet Gynecol. 139:1981;423-426.
91. Sokol R.J., Kazzi G.M., Kalhan S.C., Pillay S.K. Identifying the pregnancy at risk for intrauterine growth retardation Possible usefulness of the intravenous glucose tolerance test . Am J Obstet Gynecol. 143:1982;220-223.
92. Langer O., Damus K., Maiman M., Divon M., Levy J., Bauman W. A link between hypoglycemia-hypoinsulinemia during oral glucose tolerance tests and intrauterine growth retardation. Am J Obstet Gynecol. 155:1986;711-716.
93. Lin C.C., Moawad A.H., River P., Blix P., Abraham M., Rubenstein A.H. Amniotic fluid C-peptide as an index for intrauterine fetal growth. Am J Obstet Gynecol. 139:1981;390-396.
94. Shanklin D.R., Sibai B.M. Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol. 161:1989;735-741.
95. Abdul-Karim R., Assali N.S. Pressor response to angiotonin in pregnant and nonpregnant women. Am J Obstet Gynecol. 82:1961;246.
96. Gant N.F., Daley G.I., Chand S., Whalley P.J., MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 52:1973;2682-2689.
97. Gant N.F., Chand S., Whalley P.J., MacDonald P.C. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol. 43:1974;854-858.
98. Friedman S.A. Preeclampsia A review of the role of prostaglandins . Obstet Gynecol. 71:1988;122-137.
99. Walsh S.W. Preeclampsia An imbalance in placenta prostacyclin and thromboxane production . Am J Obstet Gynecol. 152:1985;335-340.
100. Walsh S.W., Parisi V.M. The role of arachidonic acid metabolism in preeclampsia. Semin Perinatol. 10:1986;334-355.
101. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
102. Neri I., Mazza V., Galassi M.C., Volpe A., Facchinetti F. Effects of L-arginine on utero-placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand. 75:1996;208-212.
103. Wang Y.P., Walsh S.W., Guo J.O., Zhang J.Y. Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol. 165:1991;1690-1694.
104. Wang Y.P., Walsh S.W., Guo J.O., Zhang J.Y. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol. 165:1991;1695-1700.
105. Davidge S.T., Hubel C.A., Brayden R.D., Capeless E.C., McLaughlin M.K. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol. 79:1991;897-901.
106. Di Iorio R., Marinoni E., Anceschi M.M., Emiliani S., Letizia C., Cosmi E.V. Amniotic fluid endothelin-1 levels are increased in pregnancy-induced hypertension and intrauterine growth retardation. Am J Reprod Immunol. 36:1996;260-263.
107. Wilkes K.B., Nielsen H.C., D'Alton M.E. Elevated endothelin levels are associated with increased placental resistance. Am J Obstet Gynecol. 174:1996;1599-1604.
108. McQueen J., Kingdom J.C., Connell J.M., Whittle M.J. Fetal endothelin levels and placental and vascular endothelin receptors in intrauterine growth retardation. Obstet Gynecol. 82:1993;992-998.
109. Rizzo G., Capponi A., Rinaldo D., Arduini D., Romanini C. Release of vasoactive agents during cordocentesis Differences between normally grown and growth-restricted fetuses . Am J Obstet Gynecol. 175:1996;563-570.
110. Seligman S.P., Buyon J.P., Clancy R.M., Young B.K., Abramson S.B. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 171:1994;944-948.
111. Lyall F., Young A., Greer I.A. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol. 173:1995;714-718.
112. Silver R.K., Kupferminc M.J., Russel T.L., Alder L., Mullen T.A., Caplan M.S. Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol. 175:1996;1013-1017.
113. Smarason A.K., Allman K.G., Young D., Redman C.W. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with preeclampsia. Br J Obstet Gynaecol. 107:1997;538-543.
114. Chaudhuri G., Cuevas J., Guba G.M., Ignarro L.J. NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels. Am J Physiol. 265:1993;H2036-H2043.
115. Larsson N.G., Wang J., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet. 19:1998;231-236.
116. Lane R.H., Chandoorkar A.K., Flozak A.S., Simmons R.A. Intrauterine growth retardation alters mitochondrial gene expression and function in fetal and juvenile rat skeletal muscle. Pediatr Res. 43:1998;563-570.
117. Saito S., Umekage H., Morikawa H. Involvement of cytokines in pathogenesis of EPH gestosis. Nakabayashi M., Araki T. Recent advances on the pathophysiology of pregnancy. 1997;97-100 Organization Committee Print, Japan.
118. Fuji T., Hamai Y., Hara N., Yamashita T., Kozyma S., Taketani Y. The role of interleukin-2 in pathophysiology of preeclampsia. Nakabayashi M., Araki T. Recent advances on the pathophysiology of pregnancy. 1997;101-106 Organization Committee Print, Japan.
119. Loke Y.W., King A. Immunology of human placental implantation clinical implications of our current understanding . Mol Med Today. 4:1997;153-159.
120. Khong T.Y., De Wolf F., Robertson W.B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational-age infants. Br J Obstet Gynaecol. 93:1986;1049-1059.
121. Chard T. Insulin-like growth factors and their binding proteins in normal and abnormal fetal growth a review . Growth Regul. 4:1994;91-100.
122. Wang H.S., Chard T. The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the control of human fetal growth. J Endocrinol. 132:1992;11-19.
123. Wang H.S., Lim J., English J., Irvine L., Chard T. The concentration of insulin-like growth factor-I and insulin-like growth factor binding protein-1 in human umbilical cord serum at delivery Relation to fetal weight . J Endocrinol. 129:1991;459-464.
124. Guidice L.C., deZegher F., Gargosky S.E., Dsupin B.A., de las Fuentes L., Crystal R.A., et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 80:1995;1548-1555.
125. Pannier E.M., Irwin J.C., Guidice L.C. Insulin-like growth factor-binding proteins in the human fetus tissue-specific protein secretion, immunologic characterization, and gene expression . Am J Obstet Gynecol. 171:1994;746-752.
126. Guidice L.C., Martina N.A., Crystal R.A., Taguke S., Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor II, and insulin-like growth factor binding protein-1 in the circulation of women in severe preeclampsia. Am J Obstet Gynecol. 176:1997;751-758.